Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2002 1
2006 1
2008 2
2009 1
2011 1
2015 2
2016 1
2017 6
2018 7
2019 20
2020 21
2021 19
2022 19
2023 19
2024 24
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.
Braun DA, Hou Y, Bakouny Z, Ficial M, Sant' Angelo M, Forman J, Ross-Macdonald P, Berger AC, Jegede OA, Elagina L, Steinharter J, Sun M, Wind-Rotolo M, Pignon JC, Cherniack AD, Lichtenstein L, Neuberg D, Catalano P, Freeman GJ, Sharpe AH, McDermott DF, Van Allen EM, Signoretti S, Wu CJ, Shukla SA, Choueiri TK. Braun DA, et al. Among authors: jegede oa. Nat Med. 2020 Jun;26(6):909-918. doi: 10.1038/s41591-020-0839-y. Epub 2020 May 29. Nat Med. 2020. PMID: 32472114 Free PMC article.
Safety of Stimulants Across Patient Populations: A Meta-Analysis.
Oliva HNP, Prudente TP, Mayerson TF, Mignosa MM, Oliva IO, Potenza MN, Jegede OO, Angarita GA. Oliva HNP, et al. Among authors: jegede oo. JAMA Netw Open. 2025 May 1;8(5):e259492. doi: 10.1001/jamanetworkopen.2025.9492. JAMA Netw Open. 2025. PMID: 40343695 Free PMC article.
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma.
Hugaboom MB, Wirth LV, Street K, Ruthen N, Jegede OA, Schindler NR, Shah V, Zaemes JP, El Ahmar N, Matar S, Savla V, Choueiri TK, Denize T, West DJ, McDermott DF, Plimack ER, Sosman JA, Haas NB, Stein MN, Alter R, Bilen MA, Hurwitz ME, Hammers H, Signoretti S, Atkins MB, Wu CJ, Braun DA. Hugaboom MB, et al. Among authors: jegede oa. Cancer Discov. 2025 May 2;15(5):948-968. doi: 10.1158/2159-8290.CD-24-0991. Cancer Discov. 2025. PMID: 39992403 Free PMC article.
Identification of genetic subtypes in follicular lymphoma.
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, Bakhtiari M, Calvente L, Hong M, He MY, Modi S, Hershenfeld SA, Ludvigsen M, Madsen C, Hamilton-Dutoit S, d'Amore FA, Brodtkorb M, Johnson NA, Baetz T, LeBrun D, Tobin JWD, Gandhi MK, Mungall AJ, Xu W, Ben-Neriah S, Steidl C, Delabie J, Tremblay-LeMay R, Jegede O, Weigert O, Kahl B, Evens AM, Kridel R. Shelton V, et al. Among authors: jegede o. Blood Cancer J. 2024 Aug 7;14(1):128. doi: 10.1038/s41408-024-01111-w. Blood Cancer J. 2024. PMID: 39112453 Free PMC article.
Risperidone-Associated Atrioventricular Block.
Jegede O, Taher K. Jegede O, et al. Am J Ther. 2019 Sep/Oct;26(5):e610-e612. doi: 10.1097/MJT.0000000000000810. Am J Ther. 2019. PMID: 29927774 No abstract available.
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, Hsi ED, Witzig T, Dave S, Scott D, Hanson C, Kostakoglu Shields L, Abdel-Samad N, Casulo C, Bartlett NL, Caimi PF, Al Baghdadi T, Blum KA, Romer MD, Inwards DJ, Lerner RE, Wagner LI, Little RF, Friedberg JW, Leonard JP, Kahl BS. Smith MR, et al. Among authors: jegede oa. Blood. 2024 Sep 5;144(10):1083-1092. doi: 10.1182/blood.2024023962. Blood. 2024. PMID: 38820500 Free PMC article. Clinical Trial.
Geographical distribution of the Cryptococcus gattii species complex: a systematic review.
Poplin V, Smith C, Caceres DH, Herkert PF, Jegede O, Thompson GR 3rd, Baddley JW, Schwartz IS, Kubat R, Deka MA, Toda M, Lockhart SR, Chiller T, Hagen F, Bahr NC. Poplin V, et al. Among authors: jegede o. Lancet Microbe. 2024 Dec;5(12):100921. doi: 10.1016/S2666-5247(24)00161-7. Epub 2024 Aug 24. Lancet Microbe. 2024. PMID: 39191262 Free PMC article.
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.
Ficial M, Jegede OA, Sant'Angelo M, Hou Y, Flaifel A, Pignon JC, Braun DA, Wind-Rotolo M, Sticco-Ivins MA, Catalano PJ, Freeman GJ, Sharpe AH, Hodi FS, Motzer RJ, Wu CJ, Atkins MB, McDermott DF, Shukla SA, Choueiri TK, Signoretti S. Ficial M, et al. Among authors: jegede oa. Clin Cancer Res. 2021 Mar 1;27(5):1371-1380. doi: 10.1158/1078-0432.CCR-20-3084. Epub 2020 Nov 20. Clin Cancer Res. 2021. PMID: 33219016 Free PMC article. Clinical Trial.
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.
Zauderer MG, Jegede O, Jackman DM, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Takebe N, Huang R, Carrillo JA, Brenner AJ, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Zauderer MG, et al. Among authors: jegede o. JCO Precis Oncol. 2024 Dec;8:e2400327. doi: 10.1200/PO.24.00327. Epub 2024 Dec 18. JCO Precis Oncol. 2024. PMID: 39693587 Clinical Trial.
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.
Mantia CM, Jegede OA, Plimack ER, Powles T, Motzer RJ, Tannir NM, Lee CH, Tomita Y, Voss MH, Choueiri TK, Rini BI, Hammers HJ, Escudier B, Albigès L, Rosenblatt L, Atkins MB, Regan MM, McDermott DF. Mantia CM, et al. Among authors: jegede oa. J Immunother Cancer. 2024 Jul 25;12(7):e009495. doi: 10.1136/jitc-2024-009495. J Immunother Cancer. 2024. PMID: 39060019 Free PMC article. Clinical Trial.
141 results